<DOC>
	<DOCNO>NCT00265551</DOCNO>
	<brief_summary>The purpose study determine whether low dose high dose study drug SCA-136 effective safe treatment schizophrenia require hospitalization .</brief_summary>
	<brief_title>Study Evaluating SCA-136 Subjects With Acute Exacerbations Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Clinical diagnosis schizophrenia Ability remain hospitalized least first 4 week study Needs hospitalization due worsen schizophrenia Type 1 2 diabetes Previous use clozapine Serious medical illness schizophrenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>